Wegovy
- All
- News
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Doctors Warn Against Taking Weight-Loss Drug For 'Beach Body': "Not A Quick Fix"
Recently, Ozempic has been repurposed for weight loss, marketed under the brand name Wegovy, after clinical trials demonstrated its effectiveness in significantly reducing body weight.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Doctors Warn Against Taking Weight-Loss Drug For 'Beach Body': "Not A Quick Fix"
Recently, Ozempic has been repurposed for weight loss, marketed under the brand name Wegovy, after clinical trials demonstrated its effectiveness in significantly reducing body weight.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
